U.S. flag An official website of the United States government
  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Advancing Regulatory Science
  5. The Role of Ontology and Controlled Terminology in Precision Medicine: Implications for Post-Market Surveillance - 11/06/2019 - 11/06/2019
  1. Advancing Regulatory Science

Webcast | Virtual

Event Title
The Role of Ontology and Controlled Terminology in Precision Medicine: Implications for Post-Market Surveillance
November 6, 2019

November 6, 2019

Johns Hopkins University CERSI

Wednesday, November 6, 2019

Presented By

Picture of Christopher Chute, MD, DrPH

Christopher Chute, MD, DrPH
Bloomberg Distinguished Professor of Health Informatics
Professor of Medicine, Public Health, and Nursing
Chief Research Information Officer, Johns Hopkins Medicine
Deputy Director, Institute for Clinical and Translational Research
Johns Hopkins University

About the Presentation

Biomedicine and healthcare, including post-market surveillance of adverse events, have become data-intensive activities. The importance of data is in part because much more is available, and in part because of our ability to analyze it with modern data science tools. However, integrating data from real-world sources remains a serious challenge. The data must be comparable, more or less by definition. It is beneficial if the data is also consistent and reliable. In this talk, Dr. Chute emphasized maturing methods and techniques to frame clinical data for downstream analyses and discovery.

About the Presenter

Christopher Chute, MD, DrPH is the Bloomberg Distinguished Professor of Health Informatics, Professor of Medicine, Public Health, and Nursing at Johns Hopkins University, and the Chief Research Information Officer for Johns Hopkins Medicine. He received his undergraduate and medical training at Brown University, completed his internal medicine residency at Dartmouth University, and doctoral training in Epidemiology and Biostatistics at Harvard University. He is Board Certified in Internal Medicine and Clinical Informatics, and an elected Fellow of the American College of Physicians, the American College of Epidemiology, HL7, the American Medical Informatics Association, and the American College of Medical Informatics (ACMI). He is also a Founding Fellow of the International Academy of Health Sciences Informatics and was president of ACMI through 2018.

Dr. Chute became the founding Chair of Biomedical Informatics at Mayo Clinic in 1988, retiring from Mayo Clinic in 2014, where he remains an emeritus Professor of Biomedical Informatics. He is presently Principal Investigator on several high-profile informatics grants from NIH involving translational science. He has been active on many Health Information Technology (HIT) standards efforts and chaired ISO Technical Committee 215 on Health Informatics and the World Health Organization (WHO) International Classification of Disease Revision (ICD-11).

Dr. Chute’s career has focused on how clinical information can be represented to support analyses and inferencing, including comparative effectiveness analyses, decision support, best evidence discovery, and translational research. He has had a strong interest in semantic consistency, harmonized information models, and ontology. His current research focuses on translating basic science information into clinical practice, in particular how dysfunctional phenotypes (disease) are classified.




Please contact Jessika Alfaro at Jessika.Alfaro@fda.hhs.gov

Back to Top